Session Details

[P-DN]DNA

Wed. Oct 30, 2019 9:00 AM - 6:15 PM JST
Wed. Oct 30, 2019 12:00 AM - 9:15 AM UTC
Poster Room Exhibition Hall
Discussion
17:15 - 18:15

Viewing

[P-DN-01]Identifying host factors for HSV infection by genome-wide CRISPR screen

*Takeshi Suzuki1, Yoshitaka Sato1, Yusuke Okuno2, Fumi Goshima1, Takayuki Murata3, Takahiro Watanabe1, Hiroshi Kimura1 (1. Department of Virology, Nagoya University Graduate School of Medicine, 2. Medical Genomics Center, Nagoya University Hospital, 3. Department of Virology and Parasitology, Fujita Health University School of Medicine)

[P-DN-02]Induction of antitumor immunity of oncolytic HSV-1 HF10 for metastatic breast cancer

*Fumi Goshima1, Shinichi Esaki1,2, Gaku Takano1,2, Takahiro Watanabe1, Yoshitala Sato1, Takayuki Murata1,3, Yukihiro Nishiyama1, Hirosho Kimura1 (1. Nagoya University, 2. Nagoya City University, 3. Fujita Health University)

[P-DN-03]The efficacy of oncolytic HSV-1 HF10 for head and neck carcinoma mouse model

*Gaku Takano1,2, Shinichi Esaki1,2, Fumi Goshima1, Takahiro Watanabe1, Yoshitaka Sato1, Takayuki Murata1,3, Yukihiro Nishiyama, Hiroshi Kimura1 (1. Nagoya University, 2. Nagoya City University, 3. Fujita Health University)

[P-DN-04]A mutation in HSV-1 UL29 gene confers HSV-1 acyclovir-resistance

*souichi yamada1, Shizuko Harada1, Hikaru Fujii1, Tomoki Yoshikawa1, Takuya Inagaki1, Miho Sibamura1, Shuetsu Fukushi1, Masayuki Saijo1 (1. National Institute of Infectious Diseases)

[P-DN-05]Characterization analysis of Varicella Zoster Virus (VZV) clones isolated from vOka strain

*Shinya Okamura1, Akane Takahashi1, Kouki Murakami1, Yasuko Mori2, Koichi Yamanishi1, Hirotaka Ebina1 (1. The Research Foundation for Microbial Disease of Osaka University, 2. Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine)

[P-DN-06]Neuronal differentiation of rat cell line Rn33B reduces susceptibility to EHV-1

*Erina Minato1, Keisuke Aoshima1, Atsushi Kobayashi1, Takashi Kimura1 (1. Hokkaido University)

[P-DN-07]Prevention of fatal encephalitis in mice by immunizing with replication-defective equine herpesvirus type 1

*Noriko Fukushi1, Yassine Badr1, Keisuke Nakagawa2, Hideto Fukushi1,2 (1. Department of Applied Veterinary Sciences, United Graduated School of Veterinary Sciences, Gifu University, 2. Laboratory of Veterinary Microbiology, Faculty of Applied Biological Sciences, Gifu University)

[P-DN-08]Attenuation of human herpesvirus (HHV-) 6B and HHV-7 reactivation by aging

*Nobuyuki Kobayashi1, Kazuya Shimada1, Toshiko Nisiyama2,3, Takashi Yamauchi2, Machi Suka2, Hiroyuki Yanagisawa2, Kazuhiro Kondo1 (1. Department of Virology, The Jikei University School of Medicine, 2. Department of Public Health and Environmental Medicine, The Jikei University School of Medicine, 3. Otemachi Sakura clinic in Toyosu)

[P-DN-09]Interactome analysis of human herpesvirus 6B-encoded tegument proteins

*Hikaru NAMBA1, Hirohito Ogawa1, Nobuko Yamashita1, Masao Yamada1 (1. Department of Virology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University)

[P-DN-10]Comprehensive analysis for humoral immune responses to Cytomegalovirus infection

*Takeharu Minamitani1,2, Tetsuro Koshizuka3, Naoki Inoue3, Teruhito Yasui1,2 (1. Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 2. Laboratory of Immunobiologics Evaluation, Center for Vaccine and Adjuvant Research (CVAR), NIBIOHN, 3. Microbiology and Immunology Laboratory, Gifu Pharmaceutical University)

[P-DN-11]Human Cytomegalovirus Latency in the Lesions of Atherosclerosis: a Histopathological Study

*Isao Kosugi1, Hideya Kawasaki1, Toshihide Iwashita1 (1. Hamamatsu University School of Medicine)

[P-DN-12]Analysis of anti-cytomegalovirus activity of immunosuppressive agent, Everolimus

*Long Tan1, Yoshihiro Yoshida1, Hideki Tani1, Kimiyasu Shiraki2 (1. Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2. Senri Kinran University)

[P-DN-13]Studies on enhancement of guinea pig CMV infection by endogenously expressed GP131 and GP133, components of the complex for cell tropisms

*Misaki Okumura1, Reina Makino1, Miku Miura(Matsuura)1, Naoki Inoue1 (1. Gifu Pharmaceutical University)

[P-DN-14]Human cytomegalovirus replication is suppressed by PLSCR1

*Hidetaka Sadanari1, Tomoki Ishida1, HIkaru Otagiri1, Shuichi Kusano2, Masaya Takemoto1, Tohru Daikoku1, Tsugiya Murayama1 (1. Hokuriku University, 2. Kagoshima University)

[P-DN-15]CDK inhibitors that control late gene transcription of Epstein-Barr virus also suppress the transcription of HCMV

*Miki Umeda1, Yoshitaka Sato2, Hiroshi Kimura2, Tohru Daikoku1 (1. Department of Microbiology and Immunology, Faculty of Pharmaceutical Sciences, Hokuriku University, 2. Department of Virology,Nagoya University Graduate School of Medicine)

[P-DN-16]EBV infection is prevalent in the adenoid and palatine tonsils in adults

*Satoru Kondo1 (1. Division of otolaryngology, head and neck surgery, graduate school of medical science, Kanazawa university)

[P-DN-17]Whole-genome cloning of Epstein–Barr virus strains from asymptomatically infected individuals

*Misako Yajima1, Kazufumi Ikuta1, Teru Kanda1 (1. Tohoku Medical and Pharmaceutical University)

[P-DN-18]Study of EBV-reactivation by thermal stimulation in EBV-positive cells

*Ryo Kobayashi1, Shigeki Nakamura1, Tetsuya Matsumoto1,2 (1. Tokyo Medical University, 2. International University of Health and Welfare)

[P-DN-19]Expression of CCL17 and CCL22 chemokines in EBV-positive pyothorax-associated lymphoma attracts CCR4-expressing regulatory T cells

*Tomonori Higuchi Higuchi1, Yumiko Hashida1, Tomohiro Nishimori1, Masanori Daibata1 (1. Department of Microbiology and Infection, Kochi Medical School, Kochi University)

[P-DN-20]Production of recombinant KSHV vIL-6 and development of a new monoclonal antibody

*Takayuki Kanno1, Yuko Sato1, Kaori Sano1, Tadaki Suzuki1, Hideki Hasegawa1, Harutaka Katano1 (1. Department of Pathology, National Institute of Infectious Diseases)

[P-DN-21]Transactivation of CD274/PD-L1 Gene Promoter by KSHV RTA/ORF50 and Cellular SP1 Proteins

*Kohji Noguchi1,2, Masanori Miyazawa2, Kazuhiro Katayama2,3, Yoshikazu Sugimoto2 (1. Yokohama University of Pharmacy, 2. Faculty of Pharmacy, Keio University, 3. School of Pharmacy, Nihon University)

[P-DN-22]Importin β1 regulates cell growth and survival of KSHV-infected primary effusion lymphoma

*Naoki Mori1, Chie Ishikawa1,2 (1. Department of Microbiology and Oncology, University of the Ryukyus, 2. Transdisciplinary Research Organization for Subtropics and Island Studies, University of the Ryukyus)

[P-DN-23]Isolation and characterization of adenovirus from throat/nasal swab sample of an African pigmy hedgehog presenting respiratory symptoms

*Hideharu Ochiai1, Hiroo Madarame1, Yukie Katayama2, Kaoru Suzuki2, Kenichi Tamukai3, Nanako Osawa2, Tetsuya Mizutani2 (1. Azabu University, 2. Tokyo University of Agriculture and Technology, 3. Den-en-chofu Animal Hospital)

[P-DN-24]Scyl2 inhibits Adenovirus release from host cells

*Masaru Shimada1, Akio Yamashita2, Akiko Okayama3, Hisashi Hirano3, Nobuhisa Mizuki4, Kenji Okuda1 (1. Dept. Microbiology,Yokohama City University, 2. Dept. Molecular Biology,Yokohama City University, 3. Research Center, Yokohama City University, 4. Dept. Ophthalmology and Visual scinece, Yokohama City University)

[P-DN-25]Sequence analysis of human papillomavirus genotype 18 isolated from Japanese women

*Mayuko Naka1,2, Yuri Tenjimbayashi1, Yusuke Hirose1, Mamiko Onuki1, Takashi Iwata3, Koji Matsumoto1, Iwao Kukimoto2 (1. Department of Obstetrics and Gynecology, Showa University School of Medicine, 2. Pathogen Genomics Center, National Institute of Infectious Diseases, 3. Department of Obstetrics and Gynecology, Keio University School of Medicine)

[P-DN-26]Development of a tissue culture system enabling real-time monitoring of the HPV genome maintenance and transcription by generating novel HPV16 based replicons.

*tomomi Nakahara1, Tohru Kiyono1 (1. National Cancer Center Research Institute)

[P-DN-27]TRANSCRIPTIONAL FACTOR TEAD1 AND ITS COFACTOR VGLL1 ARE REQUIRED FOR TRANSCRIPTION OF HPV16 EARLY GENES

*Seiichiro Mori1, Iwao Kukimoto1 (1. National Institute of Infectious Diseases)

[P-DN-28]The homeobox-transcription factor HOXC13 up-regulates the human papillomavirus early promoter and contributes to viral genome maintenance

*Yoshiyuki Ishii1, Ayumi Taguchi2,3, Iwao Kukimoto1 (1. National Institute of Infectious Diseases, 2. Komagome Hospital, 3. The University of Tokyo)

[P-DN-29]Establishing in vitro-replication system for Trichodysplasia-spinulosa associated polyomavirus

*Toshie Nako1,2, Hitomi Fukumoto1, Michiyo Kataoka1, Tian-Cheng Li 3, Satoko Matsunaga4, Akihide Ryo4, Hideki Hasegawa1, Hidehisa Saeki2, Harutaka Katano1 (1. Department of Pathology, National Institute of Infectious Diseases, 2. Department of Dermatology, Nippon Medical School, 3. Department of Virology II, National Institute of Infectious Diseases, 4. Department of Microbiology, Yokohama City University School of Medicine)

[P-DN-30]Epidemiological study of human polyomavirus 6 and human polyomavirus 7 in normal skin of healthy individuals

*Yumiko Hashida1, Tomonori Higuchi1, Tomohiro Nishimori1, Masanori Daibata1 (1. Department of Microbiology and Infection, Kochi Medical School, Kochi University)

[P-DN-31]Reporter-based neutralization assay for JC polyomavirus

*Mami Matsuda1, Tian-Cheng Li1, Akira Nakanishi2, Masamichi Muramatsu1, Tetsuro Suzuki3, Ryosuke Suzuki1 (1. National Institute of Infectious Diseases, 2. Kindai University , 3. Hamamatsu University School of Medicine)

[P-DN-32]Replication of PML-type JC polyomavirus clones in cultured cells

*Souichi Nukuzuma1, Chiyoko Nukuzuma2, Masanori Kameoka3, Shigeki Sugiura4, Kazuo Nakamichi5, Takafumi Tasaki6, Koushi Hidaka7, Tsutomu Takegami8 (1. Department of Infectious Diseases, Kobe Institute of Health, 2. Thermocell Inc., 3. Department of Public Health, Kobe University Graduate School of Health Sciences, 4. Medical Genetics Research Center, Nara Medical University, 5. Department of Virology1, National Institute of Infectious Diseases, 6. Divison of Protein Regulation Research, Medical Research Institute, Kanazawa Medical University, 7. Faculty of Pharmaceutical Sciences, Cooperative Research Center for Life Sciences, Kobe Gakuin University, 8. Division of Molecular Oncology and Virology, Medical Research Institute, Kanazawa Medical University)

[P-DN-33]Laboratory surveillance of progressive multifocal leukoencephalopathy in patients with autoimmune disorders

*Kazuo Nakamichi1, Masayuki Saijo1 (1. Department of Virology 1, National Institute of Infectious Diseases)

[P-DN-34]Viral DNA variants in human polyomavirus BK-induced rodent tumor cell lines

*Setsuko Shioda1, Fumio Kasai1, Midori Ozawa1, Azusa Ohtani1, Masashi Iemura1, Arihiro Kohara1 (1. National Institute of Biomedical Innovation, Health and Nutrition)

[P-DN-35]Productive method for laboratory strain of BK polyomavirus using A549 cell

*TAKERU URAYAMA1, Kadue Takahashi1, Syoji ideno1, Mikihiro Yunoki2, Kaoru Sakai1, Hidetaka Maeno1, Mitsuru Saito3, Kazuyuki Numakura3, Yoko Mitobe3, Souichi Nukuzuma4, Shigeru Satoh5 (1. Central Research Laboratory, Japan Blood Products Organization, 2. Research & Development Division, Japan Blood Products Organization, 3. Department of Urology, Akita University Graduate School of Medicine , 4. Department of Infectious Diseases, Kobe Institute of Health, 5. Center for Kidney Disease and Transplantation, Akita University Hospital)

[P-DN-36]Virus like particle formation of human parvovirus B19 in Nicotiana benthamiana.

*Sakika Kimura1, Akio Suzuki2, Hirotaka Ebina2, Eiji Morita1 (1. Department of Biochemistry and Molecular Biology, Hirosaki University, 2. The Research Foundation for Microbial Diseases of Osaka University)